Close Menu

NEW YORK (GenomeWeb) – Personalized Wellness firm Arivale has suspended its direct-to-consumer business, stating on its website that the genetic, microbiome, and other lab tests involved in its coaching and monitoring service remain too costly for its business model to succeed at this time.

The timing is abrupt, considering that the company was anticipating a new study describing results in 2,500 participants, which it said has now been accepted for publication in Scientific Reports.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.